Back
Cidara Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
62
CDTX
Cidara Therapeutics
Last Price:
13.18
Seasonality Move:
7.06%
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
65.78
Seasonality Move:
13.3%
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $13.03. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.00. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $13.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 65.74 | Buy |
| Chaikin Money Flow: | -17467 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.44 - 12.42) | Buy |
| Bollinger Bands (100): | (11.01 - 12.73) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.93 | Sell |
| Relative Strength Index (14 RSI): | 29.43 | Sell |
| Chaikin Money Flow: | -205272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.87 - 70.73) | Sell |
| Bollinger Bands (100): | (71.95 - 88.51) | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.7 | Buy |
| 20-day SMA: | 11.59 | Buy |
| 50-day SMA: | 11.53 | Buy |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 12.66 | Buy |
| 20-day EMA: | 11.99 | Buy |
| 50-day EMA: | 11.74 | Buy |
| 200-day EMA: | 13.15 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.17 | Sell |
| 20-day SMA: | 69.24 | Sell |
| 50-day SMA: | 75.04 | Sell |
| 200-day SMA: | 82.85 | Sell |
| 8-day EMA: | 67.65 | Sell |
| 20-day EMA: | 69.3 | Sell |
| 50-day EMA: | 73.55 | Sell |
| 200-day EMA: | 81.57 | Sell |
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $17.37 per share, and an increase next year of $26.43 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Cidara Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||